Datametrex AI Limited (DTMXF) has completed the acquisition of Arbutus Health and Wellness Inc., a Vancouver-based multidisciplinary medical clinic. The acquisition was executed through a share exchange agreement dated June 5, 2025, where Datametrex acquired 100% of Arbutus Health's shares in exchange for 11 million common shares at $0.10 per share, valued at $1.1 million. Arbutus Health offers various healthcare services including walk-in services, family medicine, and skin laser treatments in a single location. The transaction, which requires final TSXV approval, will not result in any debt assumption, fundamental change, or change of control for Datametrex. The acquisition aligns with Datametrex's strategy to expand its healthcare sector presence.
Datametrex AI Limited (DTMXF) ha completato l'acquisizione di Arbutus Health and Wellness Inc., una clinica medica multidisciplinare con sede a Vancouver. L'acquisizione 猫 stata realizzata tramite un accordo di scambio azionario datato 5 giugno 2025, in cui Datametrex ha acquisito il 100% delle azioni di Arbutus Health in cambio di 11 milioni di azioni ordinarie al prezzo di 0,10 dollari per azione, per un valore complessivo di 1,1 milioni di dollari. Arbutus Health offre diversi servizi sanitari, tra cui servizi senza appuntamento, medicina di famiglia e trattamenti laser per la pelle, tutto in un'unica sede. L'operazione, che necessita dell'approvazione finale della TSXV, non comporter脿 alcun debito, cambiamento fondamentale o modifica del controllo per Datametrex. Questa acquisizione si inserisce nella strategia di Datametrex di espandere la propria presenza nel settore sanitario.
Datametrex AI Limited (DTMXF) ha completado la adquisici贸n de Arbutus Health and Wellness Inc., una cl铆nica m茅dica multidisciplinaria con sede en Vancouver. La adquisici贸n se llev贸 a cabo mediante un acuerdo de intercambio de acciones fechado el 5 de junio de 2025, en el que Datametrex adquiri贸 el 100% de las acciones de Arbutus Health a cambio de 11 millones de acciones comunes a 0,10 d贸lares por acci贸n, valoradas en 1,1 millones de d贸lares. Arbutus Health ofrece diversos servicios de salud, incluyendo atenci贸n sin cita previa, medicina familiar y tratamientos l谩ser para la piel, todo en una sola ubicaci贸n. La transacci贸n, que requiere la aprobaci贸n final de la TSXV, no implicar谩 asunci贸n de deuda, cambios fundamentales ni cambio de control para Datametrex. Esta adquisici贸n est谩 alineada con la estrategia de Datametrex para ampliar su presencia en el sector salud.
Datametrex AI Limited (DTMXF) a finalis茅 l'acquisition d'Arbutus Health and Wellness Inc., une clinique m茅dicale multidisciplinaire bas茅e 脿 Vancouver. L'acquisition a 茅t茅 r茅alis茅e via un accord d'茅change d'actions dat茅 du 5 juin 2025, par lequel Datametrex a acquis 100 % des actions d'Arbutus Health en 茅change de 11 millions d'actions ordinaires 脿 0,10 $ chacune, pour une valeur totale de 1,1 million de dollars. Arbutus Health propose divers services de sant茅, notamment des consultations sans rendez-vous, la m茅decine familiale et des traitements au laser pour la peau, le tout dans un m锚me 茅tablissement. La transaction, soumise 脿 l'approbation finale de la TSXV, n'entra卯nera aucune prise en charge de dette, changement fondamental ou changement de contr么le pour Datametrex. Cette acquisition s'inscrit dans la strat茅gie de Datametrex visant 脿 renforcer sa pr茅sence dans le secteur de la sant茅.
Datametrex AI Limited (DTMXF) hat die 脺bernahme von Arbutus Health and Wellness Inc., einer multidisziplin盲ren medizinischen Klinik mit Sitz in Vancouver, abgeschlossen. Die 脺bernahme erfolgte durch eine Aktienaustauschvereinbarung vom 5. Juni 2025, bei der Datametrex 100 % der Aktien von Arbutus Health im Austausch f眉r 11 Millionen Stammaktien zu je 0,10 USD erworben hat, was einem Wert von 1,1 Millionen USD entspricht. Arbutus Health bietet verschiedene Gesundheitsdienstleistungen an, darunter Walk-in-Services, Familienmedizin und Laser-Hautbehandlungen, alles an einem Standort. Die Transaktion, die der endg眉ltigen Genehmigung der TSXV bedarf, f眉hrt zu keiner Schulden眉bernahme, keiner grundlegenden 脛nderung oder Kontrollwechsel bei Datametrex. Die 脺bernahme entspricht der Strategie von Datametrex, seine Pr盲senz im Gesundheitssektor auszubauen.
Positive
Strategic expansion into healthcare sector through acquisition of a multidisciplinary medical clinic
All-stock transaction valued at $1.1M with no debt assumption
Acquisition provides immediate access to multiple revenue streams through various medical services
Transaction structure maintains company control and doesn't constitute a fundamental change
Negative
11 million new shares issuance causing dilution to existing shareholders
Transaction completion still subject to final TSXV approval
Integration risks of combining healthcare operations with existing business
TORONTO, ON / / June 6, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that further to its news release dated April 1, 2025, it has completed the acquisition of all of the issued and outstanding share capital of Arbutus Health and Wellness Inc. ("Arbutus Health"), a multidisciplinary medical clinic in Vancouver, Canada.
Arbutus Health provides walk-in services, family medicine, skin laser treatments, and other specialty healthcare services in a single location. Once operational, the clinic will be staffed by licensed healthcare professionals and will provide patients with access to multiple medical services without requiring multiple referrals.
The acquisition of Arbutus was completed by way of a share exchange agreement dated June 5, 2025 between the Company, Arbutus and the shareholders of Arbutus pursuant to which Datametrex acquires 100% of the issued and outstanding shares of Arbutus Health, an arm's length party, in exchange for an aggregate of 11,000,000 common shares of Datametrex at a deemed value of $0.10 per share (the "Payment Shares"). As a result of the transaction, Arbutus is now a wholly-owned subsidiary of Datametrex.
Upon completion of the Transaction, Paul Haber, the CEO of the Company, commented, "We are excited to finalize this agreement and are eager to integrate the Arbutus Health team into Datametrex. This acquisition marks a key milestone in broadening our product portfolio and enhancing our presence in the healthcare sector."
Issuance of the Payment Shares is subject to the receipt of regulatory approvals including, without limitation, the final approval of the TSX Venture Exchange ("TSXV") and other conditions.
Datametrex has not assumed any debt of Arbutus and the proposed acquisition will not constitute a fundamental change or result in a change of business for the Company, nor is it expected to result in a change of control of the Company within the meaning of applicable securities laws and defined in the polices of the TSXV.
About Arbutus Health
Arbutus Health is a multidisciplinary medical clinic designed to address wait times and fragmented care in Canada's health system. Walk-in services, family doctors, skin laser treatments, and other specialties are integrated under one roof to provide timely and comprehensive care without requiring multiple referrals. Staffed by licensed healthcare professionals, patient satisfaction will be enhanced through innovative, efficient, and high-quality healthcare solutions.
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our .
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir CEO & Chairman [email protected] (416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at .
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: Datametrex AI Ltd.
View the original on ACCESS Newswire
FAQ
What is the value of Datametrex's acquisition of Arbutus Health?
Datametrex acquired Arbutus Health for 11 million common shares at $0.10 per share, valued at $1.1 million.
What services does Arbutus Health and Wellness provide?
Arbutus Health provides walk-in services, family medicine, skin laser treatments, and other specialty healthcare services in a single location in Vancouver.
How will DTMXF pay for the Arbutus Health acquisition?
The acquisition is being paid entirely in shares, with Datametrex issuing 11 million common shares at $0.10 per share to Arbutus Health shareholders.
Will the Arbutus Health acquisition change control of Datametrex (DTMXF)?
No, the acquisition will not result in a change of control or fundamental change for Datametrex according to the press release.
What regulatory approvals are needed for the DTMXF-Arbutus Health deal?
The transaction requires final approval from the TSX Venture Exchange (TSXV) for the issuance of the Payment Shares.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, to receive support.
